Samuel Bjork
Partner · Digitalis Ventures
Samuel Bjork, a Partner at Digitalis Ventures, primarily invests in **biotech**, **therapeutics**, and **digital health** at the **Seed** and **Series A** stages, with check sizes typically ranging from **
00K to $5.0M** (sweet spot ~
.5M) [1][2][4]. His notable portfolio includes board directorships at **Judo Bio**, **T-Therapeutics**, **EpiBiologics**, and **Bonum Therapeutics**, alongside in…
- Stages: Pre-Seed, Seed, Series A
- Focus: Healthcare
- Location: New York, New York, United States
LinkedIn
Browse all investors · Browse founders
